Pages that link to "Q72708506"
Jump to navigation
Jump to search
The following pages link to Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group (Q72708506):
Displaying 50 items.
- Heparin versus placebo for non-ST elevation acute coronary syndromes (Q24193744) (← links)
- Heparin versus placebo for acute coronary syndromes (Q24243000) (← links)
- Acute management of unstable angina and non-ST segment elevation myocardial infarction (Q26783157) (← links)
- Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade (Q26824864) (← links)
- (Q26829973) (← links)
- Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes (Q28165924) (← links)
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators (Q28176380) (← links)
- General pharmacologic treatment of acute myocardial infarction (Q28184207) (← links)
- A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease (Q28186283) (← links)
- Antithrombotic therapy in acute coronary syndromes: key notes from ESSENCE and TIMI 11B (Q28186369) (← links)
- Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy (Q28192025) (← links)
- Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups (Q28192886) (← links)
- New anticoagulants in ischemic heart disease (Q28193160) (← links)
- Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial (Q28193437) (← links)
- Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation (Q28193946) (← links)
- The role of aspirin resistance in the treatment of acute coronary syndromes (Q28221026) (← links)
- Management of Acute Ischemic Coronary Syndromes: The Present and Future (Q30305538) (← links)
- Anticoagulants in acute coronary syndromes (Q33330179) (← links)
- Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes (Q33334039) (← links)
- The use of Low Molecular Weight Heparin to Predict Clinical Outcome in Patients with Unstable Angina That Had Undergone Percutaneous Coronary Intervention (Q33357627) (← links)
- Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin (Q33381356) (← links)
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina (Q33502560) (← links)
- Advances in the medical management of acute coronary syndromes (Q33655204) (← links)
- Thrombosis and coagulation abnormalities in the acute coronary syndromes (Q33671919) (← links)
- Anticoagulant therapy in unstable angina. (Q33671937) (← links)
- Antiplatelet therapy for treatment of acute coronary syndromes (Q33671940) (← links)
- "Traditional" medical therapy for unstable angina. How important? How to use? (Q33671947) (← links)
- Management of high-risk subsets in unstable angina (Q33671970) (← links)
- Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction (Q33699818) (← links)
- Low-molecular-weight heparin should replace unfractionated heparin in the management of acute coronary syndromes (Q33704601) (← links)
- Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: applicability to the practice of medicine in the United States (Q33754183) (← links)
- Regular review: treatment possibilities for unstable angina (Q33802938) (← links)
- Low-molecular-weight heparins for acute coronary syndromes: an emergency medicine perspective (Q33803415) (← links)
- Long-term management--the way forward? (Q33841036) (← links)
- Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease (Q33843641) (← links)
- Non ST-elevation acute coronary syndrome. (Q33846765) (← links)
- Low molecular weight heparin in acute coronary syndromes (Q34027303) (← links)
- Low molecular weight heparins and coronary artery disease (Q34027403) (← links)
- Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: role in the emergency department (Q34069662) (← links)
- The role of low-molecular-weight heparins in arterial diseases: optimizing antithrombotic therapy (Q34071460) (← links)
- American Heart Association/American College of Cardiology Foundation guide to warfarin therapy (Q34196283) (← links)
- Anticoagulation and the heart (Q34441606) (← links)
- Bivalirudin: a review of its potential place in the management of acute coronary syndromes (Q34585171) (← links)
- Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarction. (Q34995139) (← links)
- The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb (Q35114692) (← links)
- Low molecular weight heparin (enoxaparin) in the management of unstable angina: the ESSENCE study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events. (Q35578899) (← links)
- The role of low-molecular-weight heparins in cardiovascular medicine (Q35591215) (← links)
- Recent advances in the management of unstable angina and non-Q-wave myocardial infarction (Q35803300) (← links)
- A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients (Q36363183) (← links)
- Potential role of rivaroxaban in patients with acute coronary syndrome (Q36433688) (← links)